| Firm |
Analyst |
| Argus Research Company |
David Tuong |
| Baird |
Eric Coldwell |
| Barclays |
Luke Sergott |
| BofA Securities |
Michael Ryskin |
| Citi |
Patrick Donnelly |
| Deutsche Bank |
Pito Chickering |
| Evercore ISI |
Elizabeth Anderson |
| J.P. Morgan |
Lisa Gill |
| Jefferies & Co. |
Tycho Peterson |
| Leerink Partners |
Michael Cherny |
| Mizuho Securities USA Inc. |
Ann Hynes |
| Morgan Stanley |
Erin Wright |
| Morningstar, Inc. |
Deborah Wang |
| Nephron Healthcare Investment Research |
Jack Meehan |
| Piper Sandler |
David Westenberg |
| Truist Securities |
David MacDonald |
| UBS |
Kevin Caliendo |
| William Blair & Company, L.L.C. |
Andrew Brackmann |
Quest Diagnostics is followed by the analysts listed above. Please note that any opinions, estimates or
forecasts regarding Quest Diagnostics's performance made by these analysts are theirs alone and do not represent
opinions, forecasts or predictions of Quest Diagnostics or its management. Quest Diagnostics does not by its
reference above or distribution imply its endorsement of or concurrence with such information, conclusions or
recommendations.